~~<i id='6BC791363A'><strike id='6BC791363A'><tt id='6BC791363A'><pre id='6BC791363A'></pre></tt></strike></i>~~

Home» Wikipedia» leisure time

leisure time

author：fashion 2025-09-27 11:20:08 Page View：8

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Genentech weighs delaying cancer therapy after drug pricing law
Next article： In age of alternative facts, a scholarly course on calling out crap

explore

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

Pharma budget tightening trickles down to Doximity

AdobeYou’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifesciences. Sign

State Dept. review finds Biden bears some blame for Afghanistan failures

3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

1:21HunterBidendepartstheJ.CalebBoggsFederalBuildingandUnitedStatesCourthouseonJuly26,2023inWilmingt